Journal of Gastrointestinal Surgery

, Volume 15, Issue 7, pp 1168–1172 | Cite as

Use of Intraoperative Ablation as an Adjunct to Surgical Resection in the Treatment of Recurrent Colorectal Liver Metastases

  • Anand Govindarajan
  • Dean Arnaoutakis
  • Michael D’Angelica
  • Peter J. Allen
  • Ronald P. DeMatteo
  • Leslie H. Blumgart
  • William R. Jarnagin
  • Yuman Fong
2010 SSAT Poster Presentation



To evaluate the role of intraoperative ablation as an adjunct to resection in patients with recurrent colorectal liver metastases (rCLM).


All patients undergoing curative-intent reoperative surgery for rCLM from 1992 to 2009 at a tertiary cancer center were included. Overall survival (OS) and recurrence-free survival (RFS) were compared between patients treated with resection alone or in combination with ablation.


A total of 112 reoperative hepatectomies were performed, of which 16 were combined with ablation. The proportion of patients treated with resection and ablation increased from 0% to 41%. Patients undergoing resection and ablation had a greater tumor burden (median, 4 vs. 1, p < 0.0001) and higher baseline clinical risk scores (median, 3 vs. 2, p = 0.065) than patients undergoing resection alone. Patients undergoing resection and ablation had lower intraoperative blood loss than patients undergoing resection alone (344 vs. 877 ml, p = 0.018). Five-year OS from the time of surgery was 48.6%. In multivariable analysis, there was no significant difference in OS or RFS based on the treatment modality.


In patients with rCLM, the use of intraoperative ablation can extend the limits of surgical resection in patients with disease that might otherwise not be amenable to complete resection.


Colorectal cancer Liver metastases Ablation Surgery 


  1. 1.
    Benoist S and Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 2009; 16(9):2385–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH and D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25(29):4575–80.PubMedCrossRefGoogle Scholar
  3. 3.
    Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309–18; discussion 318–21.PubMedCrossRefGoogle Scholar
  4. 4.
    Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L and Fong Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002; 235(6):863–71.PubMedCrossRefGoogle Scholar
  5. 5.
    de Jong MC, Mayo SC, Pulitano C, Lanella S, Ribero D, Strub J, Hubert C, Gigot JF, Schulick RD, Choti MA, Aldrighetti L, Mentha G, Capussotti L and Pawlik TM. Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 2009; 13(12):2141–51.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishio H, Hamady ZZ, Malik HZ, Fenwick S, Rajendra Prasad K, Toogood GJ and Lodge JP. Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol 2007; 33(6):729–34.PubMedGoogle Scholar
  7. 7.
    Sa Cunha A, Laurent C, Rault A, Couderc P, Rullier E and Saric J. A second liver resection due to recurrent colorectal liver metastases. Arch Surg 2007; 142(12):1144–9; discussion 1150.PubMedCrossRefGoogle Scholar
  8. 8.
    Ahmad A, Chen SL and Bilchik AJ. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases. Arch Surg 2007; 142(6):526–31; discussion 531–2.PubMedCrossRefGoogle Scholar
  9. 9.
    Yan TD, Lian KQ, Chang D and Morris DL. Management of intrahepatic recurrence after curative treatment of colorectal liver metastases. Br J Surg 2006; 93(7):854–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Pessaux P, Lermite E, Brehant O, Tuech JJ, Lorimier G and Arnaud JP. Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol 2006; 93(1):1–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P and Jaeck D. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12(7):1491–6.PubMedGoogle Scholar
  12. 12.
    Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, Majno P and Engerran L. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225(1):51–60; discussion 60–2.PubMedCrossRefGoogle Scholar
  13. 13.
    Fernandez-Trigo V, Shamsa F and Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 1995; 117(3):296–304.PubMedCrossRefGoogle Scholar
  14. 14.
    Tuttle TM, Curley SA and Roh MS. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol 1997; 4(2):125–30.PubMedCrossRefGoogle Scholar
  15. 15.
    Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D and Bismuth H. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 2003; 238(6):871–83; discussion 883–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K and Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239(6):818–25; discussion 825–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH and D'Angelica M. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg 2007; 142(11):1087–92.PubMedCrossRefGoogle Scholar
  18. 18.
    White RR, Avital I, Sofocleous CT, Brown KT, Brody LA, Covey A, Getrajdman GI, Jarnagin WR, Dematteo RP, Fong Y, Blumgart LH and D'Angelica M. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 2007; 11(3):256–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Mulier S, Ni Y, Jamart J, Ruers T, Marchal G and Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242(2):158–71.PubMedCrossRefGoogle Scholar
  20. 20.
    van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, van der Sijp JR, van Gulik TM, Slooter GD, Klaase JM, Putter H and Tollenaar RA. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 2006; 13(5):651–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Park IJ, Kim HC, Yu CS, Kim PN, Won HJ and Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15(1):227–32.PubMedCrossRefGoogle Scholar
  22. 22.
    Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, DeMatteo RP, D'Angelica M, Blumgart LH and Jarnagin WR. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7(8):1034–44.PubMedCrossRefGoogle Scholar
  23. 23.
    Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W and Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371(9617):1007–16.PubMedCrossRefGoogle Scholar
  24. 24.
    Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA and Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24(13):2065–72.PubMedCrossRefGoogle Scholar
  25. 25.
    Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S and Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236(4):397–406; discussion 406–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Martin RC, 2nd, Brennan MF and Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg 2002; 235(6):803–13.PubMedCrossRefGoogle Scholar
  27. 27.
    Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ and Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94(7):982–99.PubMedCrossRefGoogle Scholar
  28. 28.
    Gleisner AL, Choti MA, Assumpcao L, Nathan H, Schulick RD and Pawlik TM. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg 2008; 143(12):1204–12.PubMedCrossRefGoogle Scholar
  29. 29.
    van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JM and Verhoef C. Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy. J Gastrointest Surg 2009; 13(5):890–5.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2011

Authors and Affiliations

  • Anand Govindarajan
    • 1
  • Dean Arnaoutakis
    • 1
  • Michael D’Angelica
    • 1
  • Peter J. Allen
    • 1
  • Ronald P. DeMatteo
    • 1
  • Leslie H. Blumgart
    • 1
  • William R. Jarnagin
    • 1
  • Yuman Fong
    • 1
  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations